Pfizer to Pay $430 Million Fine over Illegal Marketing

Pfizer

Pfizer pleads guilty and agrees to a pay an unprecedented $430 million fine for the promotion of the drug Neurontin for uses not approved by the FDA. Corbis hide caption

itoggle caption Corbis

Pfizer is fined $430 million for illegal marketing practices surrounding the drug Neurontin. The unprecedented fine comes after the company admitted that the epilepsy drug was promoted for several unapproved uses, including migraines, chronic pain and bipolar disease.

States had complained that the company's marketing practices inflated the costs of the Medicaid program for the poor. NPR's Snigdha Prakash reports.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.